Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)
Clinical trial NCT01244828 · COMPLETED
Trial details
- NCT number
- NCT01244828
- Sponsor
- Organon and Co
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-05
- Primary completion
- 2014-08-21
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.